We are Wall Street's #1 independent research firm*. We have raised the art of fundamental securities research to a level that Wall Street has not experienced. Our independent third party stock research business selectively initiates Independent Research Analyst Coverage for overlooked public corporations. We identify and initiate non-traditional company research. We select micro cap stocks, small cap stocks and mid cap emerging companies with management teams focused on shareholder value, sustainable competitive advantage, and companies that demonstrate market leadership in their respective disciplines. We distribute in-depth stock market research reports that highlight the company's market opportunity, technology, management, competition and other key differentiators that may affect their short and long term valuation. Our independent research includes investment research, company research, business research and quantitative research. Our investment research includes biotech research, pharmaceutical research, technology research and other industry groups. The post Enron environment has decimated the traditional Wall Street analyst pool, disadvantaging many uncovered companies. Today, approximately 6,000 out of 9,200 public companies do not have Wall Street-Analyst Research Coverage. Independent Research Analyst Coverage is invaluable for any uncovered public company.
Company Overview
